BRAF and neoplasm: For example, a kinase-inactivating mutation (D594A) in B-Raf was shown to cooperate with oncogenic K-Ras to drive tumor progression in a C-Raf-dependent manner, as demonstrated in in vivo lung adenocarcinoma models [30,31,32].